Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: The NEFRONA study

Nephrology Dialysis Transplantation

Volumn 29, Issue 7, 2014, Pages 1415-1422

  Betriu, Angels ^a   Martinez Alonso, Montserrat ^b   Arcidiacono, Maria Vittoria ^a,b   Cannata Andia, Jorge ^c,d   Pascual, Julio ^d,e   Valdivielso, José Manuel ^a,b,d   Fernández, Elvira ^a,b,d  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL DEL MAR   (Spain)

Author keywords

atheromatosis; cardiovascular disease prevention; chronic kidney disease; subclinical; ultrasound

Indexed keywords

C REACTIVE PROTEIN; COLECALCIFEROL; PHOSPHATE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROMATOSIS; ATHEROSCLEROTIC PLAQUE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING;

ATHEROMATOSIS; CARDIOVASCULAR DISEASE PREVENTION; CHRONIC KIDNEY DISEASE; SUBCLINICAL; ULTRASOUND;

ADOLESCENT; ADULT; AGED; ATHEROSCLEROSIS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 84903828322     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu038     Document Type: Article

References (37)

1. US Renal Data System. USRDS 2003 Annual Data Report: Atlas of End- Stage Renal Disease in the United States, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Disease. 2003
2. Foley RN, Murray AM, Li SL et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999. J Am Soc Nephrol 2005.; 16: 489-495
3. Herzog CA, Asinger RW, Berger AK et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011.; 80: 572-586
4. Shamseddin MK, Parfrey PS. Sudden cardiac death in chronic kidney disease: Epidemiology and prevention. Nat Rev Nephrol 2011.; 7: 145-154
5. Keane WF, Tomassini JE, Neff DR. Lipid abnormalities in patients with chronic kidney disease: Implications for the pathophysiology of atherosclerosis. J Atheroscler Thromb 2013.; 20: 123-133
6. Coll B, Betriu A, Martinez-Alonso M et al. Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: Usefulness of non-invasive tests in cardiovascular assessment. Nephrol Dial Transplant 2010.; 25: 3017-3025
7. Fellstrom B, Holdaas H, Jardine AG et al. Effect of rosuvastatin on outcomes in chronic haemodialysis patients: Baseline data from the AURORA study. Kidney Blood Press Res 2007.; 30: 314-322
8. Wanner C, Krane V, Marz Wet al. Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): Demographic and baseline characteristics. Kidney Blood Press Res 2004.; 27: 259-266
9. Shoji T, Maekawa K, Emoto M et al. Arterial stiffness predicts cardiovascular death independent of arterial thickness in a cohort of hemodialysis patients. Atherosclerosis 2010.; 210: 145-149
10. Baigent C, Landray MJ, Reith C et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial. Lancet 2011.; 377: 2181-2192
11. Ridker PM. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein - rationale and design of the JUPITER trial. Circulation 2003.; 108: 2292-2297
12. Tonelli M, Wiebe N, Culleton B et al. Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 2006.; 17: 2034-2047
13. Mann JFE, Gerstein HC, Pogue J et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 2001.; 134: 629-636
14. Ruilope LM, Salvetti A, Jamerson K et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) Study. J Am Soc Nephrol 2001.; 12: 218-225
15. Muntner P, He J, Hamm L et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002.; 13: 745-753
16. McCullough PA, Li SY, Jurkovitz CT et al. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J 2008.; 156: 277-283
17. Nakano T, Ninomiya T, Sumiyoshi S et al. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: The Hisayama study. Am J Kidney Dis 2010.; 55: 21-30
18. Arbel Y, Halkin A, Finkelstein A et al. Impact of estimated glomerular filtration rate on vascular disease extent and adverse cardiovascular events in patients without chronic kidney disease. Can J Cardiol 2013.; 29: 1374-1381
19. ChoncholM, Whittle J, Desbien A et al. Chronic kidney disease is associated with angiographic coronary artery disease. Am J Nephrol 2008.; 28: 354-360
20. Pun PH, Smarz TR, Honeycutt EF et al. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int 2009.; 76: 652-658
21. Betriu-Bars A, Fernandez-Giraldez E. Carotid ultrasound for the early diagnosis of atherosclerosis in chronic kidney disease. Nefrologia 2012.; 32: 7-11
22. Junyent M, Martinez M, Borras M et al. Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: A prospective, multicenter, observational cohort study. BMC Nephrol 2010.; 11: 14
23. Junyent M, Martinez M, Borras M et al. Usefulness of imaging techniques and novel biomarkers in the prediction of cardiovascular risk in patients with chronic kidney disease in Spain: The NEFRONA project. Nefrologia 2010.; 30: 119-126
24. La piedra c, fernandez e, casaus mlg et al Different biological functions in PTH molecules? What are we measuring? Nefrologia 2008.; 28: 123-128
25. Stein JH, Korcarz CE, Hurst RT et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: A consensus statement from the American society of echocardiography carotid intima-media thickness task force endorsed by the society for vascular medicine. J Am Soc Echocardiogr 2008.; 21: 93-111
26. Touboul PJ, Hennerici G, Meairs S et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis 2004.; 18: 346-349
27. Nambi V, Chambless L, Folsom AR et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 2010.; 55: 1600-1607
28. Polak JF, Pencina MJ, Pencina KM et al. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 2011.; 365: 213-221
29. Kalantar-Zadeh K, Block G, Humphreys MH et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003.; 63: 793-808
30. Kabagambe EK, Ordovas JM, Tsai MY et al. Smoking, inflammatory patterns and postprandial hypertriglyceridemia. Atherosclerosis 2009.; 203: 633-639
31. Neil HAW, Cooper J, Betteridge DJ et al. All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A longterm prospective registry study. Atherosclerosis 2010.; 211: 618-623
32. Tonelli M, Muntner P, Lloyd A et al. Association between LDL-C and risk of myocardial infarction in CKD. J Am Soc Nephrol 2013.; 24: 979-986
33. Kalantar-Zadeh K, Kuwae N, Regidor DL et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006.; 70: 771-780
34. Lorenzo V, Martin M, Rufino M et al. Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients. Am J Kidney Dis 2001.; 37: 1260-1266
35. Tehrani DM, Gardin JM, Yanez D et al. Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: Cardiovascular Health Study. Atherosclerosis 2013.; 231: 246-251
36. Valdivielso JM, Coll B, Fernandez E. Vitamin D and the vasculature: Can we teach an old drug new tricks? Expert Opin Ther Targets 2009.; 13: 29-38
37. Matsushita K, van der Velde M, Astor BC et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-Analysis. Lancet 2010.; 375: 2073-2081